Injective (INJ) is currently trading at $5.66, advancing 12.02% on the day and holding near session highs. The asset sits above its MA-50 ($4.94) and MA-200 ($4.20) but remains just below the MA-20 ($5.73), indicating a bullish long-term outlook with lingering short-term resistance.
Highlights
- INJ/USD maintains a bullish longer-term structure but faces short-term selling pressure, with mixed signals from momentum indicators.
- Intraday volatility is elevated at 11.79%, with the pair gaining 12.02% and trading near session highs despite market indecision.
- Expected five-day trading range is $5.02 to $5.81, with key resistance near $5.73 and support around $5.02.
Mixed momentum as bullish structure meets resistance at key averages
Technically, INJ/USD maintains a bullish trend structure above both the MA-50 and MA-200, though it faces immediate resistance at the MA-20 ($5.73) and support at the Ichimoku Kijun level of $6.04. Momentum indicators are mixed: daily MACD is neutral, the ADX shows persistent bullish strength, while RSI has eased to 48.16 and both CCI and Stochastic RSI reflect short-term oversold conditions. The Bull/Bear Power indicates sellers' dominance in intraday momentum at -0.14, and higher timeframes flag overbought. The pair opened with a $0.18 upside gap and is trading close to its daily top with 11.79% intraday volatility, supported by the robust 12.02% daily gain, though disagreement among momentum and oscillators underscores ongoing market indecision.
Earlier, analysts noted that Injective was showing renewed bullish momentum while cautioning about overbought risks and potential volatility. The current mixed technical backdrop adds a layer of uncertainty to this outlook, making a decisive move beyond the $5.81 resistance or below $5.02 support the key scenario to monitor for signs of trend continuation or reversal.
Latest Injective News
- Forex
- Crypto